Badih Elmunzer
Professor, Gastroenterology, Internal Medicine · Wake Forest University Baptist Medical Center
Credentials: · · · ·
History
Research
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis
New England Journal of Medicine · 2012 · First of 25 authors · Corresponding · 570 citations
Endoscopy · 2014 · 444 citations
Systematic review or meta-analysis · Gastrointestinal Endoscopy · 2015 · 393 citations
- GC
46 papers
- JS
35 papers
35 papers
- MK
28 papers
- GE
26 papers
26 papers
26 papers
25 papers · 1 as a fellow
Grants
- 2025–2030
PREcision MEDicine In Achalasia--PREMEDIA
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $4.8M · Northwestern University
- 2015–2024
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $11.5M · Medical University of South Carolina
- 2013–2014
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis (SVI Study)
National Institute of Diabetes and Digestive and Kidney Diseases · U34
Contact PI · $425.1K · University of Michigan at Ann Arbor
- 2011–2013
Rectal Indomethacin to Prevent of Post-ERCP Pancreatitis in High Risk Patients
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $438.2K · University of Michigan at Ann Arbor
Clinical trials
- 2009–2011
Principal investigator · Terminated · Phase 4
University of Michigan
- 2026–2032
- 2026–2032